Tudorza pressair and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Tudorza pressair (aclidinium bromide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Proair Hfa, and have Asthma.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Tudorza pressair. It is created by eHealthMe based on reports of 6,285 people who have side effects when taking Tudorza pressair from the FDA, and is updated regularly.

What is Tudorza pressair?

Tudorza pressair has active ingredients of aclidinium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 6,309 Tudorza pressair users. Check the latest studies of Tudorza pressair.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 20, 2026

6,285 people reported to have side effects when taking Tudorza pressair.
Among them, 32 people (0.51%) have Swallowing difficulty.

Could Tudorza pressair cause Swallowing difficulty?

Among these 32 people:

How long have people been on Tudorza pressair when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Tudorza pressair? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Swallowing difficulty when taking Tudorza pressair? *

What are other drugs people take besides Tudorza pressair? *

What are other side effects people have besides Swallowing difficulty? *

Dyspnea (difficult or laboured breathing): 18 people, 56.25%
Cough: 11 people, 34.38%
Drug Ineffective: 10 people, 31.25%
Diarrhea: 9 people, 28.12%
Oropharyngeal Pain: 8 people, 25.00%
Nausea And Vomiting: 8 people, 25.00%
Weight Decreased: 8 people, 25.00%
Fall: 7 people, 21.88%
High Blood Pressure: 7 people, 21.88%
Abdominal Discomfort: 6 people, 18.75%

What are the existing conditions these people have? *

Asthma: 10 people, 31.25%
Dyspnea (difficult or laboured breathing): 6 people, 18.75%
Stress And Anxiety: 6 people, 18.75%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 6 people, 18.75%
Anaemia (lack of blood): 3 people, 9.38%
Secretion Discharge: 3 people, 9.38%
Ill-Defined Disorder: 3 people, 9.38%
Cardiac Disorder: 3 people, 9.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%
Panic Disorder: 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take Tudorza pressair and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tudorza pressair:

Tudorza pressair (6,309 reports)

Browse all side effects of Tudorza pressair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,401 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aclidinium bromide (the active ingredients of Tudorza pressair) and Tudorza pressair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.